Fairchem Organics Buyback: ₹800, 51% Accepted, Tax Trap

Fairchem Organics Limited (NSE: FAIRCHEMOR | BSE: 543252), a Fairfax-backed speciality oleo-chemicals maker, bought back 4,25,000 shares at a fixed ₹800 per share through the tender-offer route. Here is the whole deal in one screen.

Announcement CMP ₹662 as per Business Standard quote around the 20–24 November 2025 board-meeting window. Latest market price near ₹750 (NSE, early July 2026).

A buyback is when a company uses its own cash to purchase its shares from existing shareholders and then cancels them. Fewer shares remain, so each surviving share represents a slightly larger slice of the company. Fairchem chose the tender offer route: instead of buying quietly from the open market, it invited shareholders to formally offer (“tender”) their shares at a set price of ₹800, well above the roughly ₹662 the stock was trading at when the board approved the plan on 20 November 2025.

Only shareholders on the company’s books as of the record date (5 January 2026 — the cut-off that decides who is eligible) could participate. Because Fairchem set aside only ₹34 crore for the whole exercise but many more shares were offered to it, the buyback worked on a proportionate basis: the company accepted a fixed fraction of what each holder tendered and returned the rest. The proportion accepted is the acceptance ratio, and it is the single most important number for anyone who took part — far more important than the headline premium.

The tendering window ran from 8 to 14 January 2026. Once closed, accepted shares were paid for at ₹800 and permanently extinguished (cancelled), shrinking the company’s share count from 1,30,20,902 to 1,25,95,902. The whole thing is now finished.

This is where Fairchem’s buyback becomes genuinely interesting — and where most coverage stops short. The buyback was sized against the March 2025 (FY25) balance sheet, but it was executed while the FY26 business was falling apart. Look at the trajectory:

Source: Capital Market / audited results compilation. FY24 figures are approximate, derived from disclosed year-on-year change (FY25 revenue −13% and PAT −46% versus FY24). EBITDA derived from disclosed OPM. *FY24 dividend approximate.

Reported profit is an opinion; cash is a fact — so the honest question is whether this buyback was paid for out of the year’s earnings or out of the balance sheet. The arithmetic answers it plainly.

The buyback consumed roughly six years of FY26 earnings in a single stroke. Even measured against the stronger FY25 (the year it was sized on), ₹34 crore was about 1.5 times that year’s entire net profit. Add the FY25 dividend of ₹7.50 per share (roughly ₹9.8 crore) paid out in the same window, and it is clear this capital return was funded from accumulated reserves built during the FY22–FY24 upcycle, not from current operations. That is a legitimate use of a healthy balance sheet — but readers should not mistake it for the company having earned this money recently.

The offer was oversubscribed 1.96 times overall — roughly twice as many shares were offered as the company was willing to buy. That means the ₹800 price only applied to about half of what most people tendered. Here is how the two investor buckets fared. (SEBI reserves at least 15% of every buyback for small shareholders — those holding shares worth up to ₹2 lakh on the record date — which is why they got a better deal.)

Never confuse the headline premium with your return. The right measure is the blended pre-tax return = Premium % × Acceptance Ratio %, because only the accepted portion earns the premium; the rest comes back to you at the market price. Using the announcement premium of 20.85%:

*Simplified model assuming unaccepted shares are sold back at the ₹662 reference price. In reality the stock recovered after the buyback (to ~₹750 by July 2026), so holders of unaccepted shares actually gained on that leftover portion — a rare tailwind. The tax treatment below still applies to the accepted portion.

Since 1 October 2024, the tax rules on buybacks changed completely, and they quietly demolish most of the arbitrage for higher-income investors. Three things now happen:

• The entire ₹800 buyback proceeds are treated as a deemed dividend and taxed at your personal slab rate — not as capital gains.
• You get no deduction for what you paid to buy the shares against that dividend.
• Instead, your purchase cost becomes a capital loss, which you may carry forward for up to 8 assessment years to set off against future capital gains — useful only if you actually have such gains.

Read that plainly: an investor who bought near the tender-eligibility price and sits in the top bracket saw the flashy 20.85% premium shrink to roughly break-even — anywhere from a small loss to a token gain — on the accepted shares, and only if the carried-forward capital loss can be promptly used. For top-bracket investors, the buyback arbitrage largely disappears. The maths is far kinder to investors in lower slabs (or with a very low cost basis), for whom the slab-rate dividend bites less.

Fairchem’s promoter group (led by institutional promoter Fairfax India Holdings) chose not to tender a single share. That decision has two separate effects, and both are true at once:

Worth noting alongside this: domestic institutional holding fell from about 5.42% to 3.99% across the buyback quarter, and the total shareholder count dropped from roughly 32,300 to 26,600 — a chunk of smaller holders used the offer to exit.

A striking detail from the final filing: a single entity captured more than half of the entire buyback. The top five tendering shareholders were:

Rajasthan Global Securities alone accounted for 56.55% of all shares bought back — a professional arbitrage desk that built a large position specifically to tender. That single fact tells you the buyback was captured far more by informed institutional arbitrageurs than by the retail base it nominally reserves 15% for. (Notably, the same firm was still trading the stock in July 2026.)

A buyback is one of two things a company can do with spare capital — return it, or reinvest it. Fairchem chose to return it at a moment when its returns on capital had thinned dramatically. On FY26’s ₹5.54 crore of profit against a net worth of a few hundred crore, return on equity fell to the low single digits, and the stock’s trailing P/E ballooned above 160–170x simply because the “E” had shrivelled.

In that light the ₹34 crore buyback reads as a modest, defensive return of surplus capital from a business that could not, in the current down-cycle, redeploy it at attractive rates — rather than a confident signal of undervaluation. Management has publicly targeted ₹2,000 crore revenue by FY30 with margin recovery; whether reserves are better spent buying back stock or funding that growth is the real capital-allocation debate here. Precise net-worth and cash-balance figures from the audited balance sheet are recorded as “Not Disclosed by Company” within the buyback filings.

ShareBazaar Online does not issue Buy, Sell or Hold calls. The points above are for understanding only; investment decisions are entirely your own.

This report is published by ShareBazaar Online for informational and educational purposes only. It does not constitute investment, legal or tax advice, and it contains no Buy, Sell or Hold recommendation of any kind. Figures marked from company filings are drawn from Fairchem Organics’ Post Buyback Public Announcement dated 22 January 2026; other data points (market prices, financial results, ratios) are sourced from publicly available exchange and market-data providers and are cited with their dates in the body of the report. Some balance-sheet line items were not disclosed within the buyback documents and are marked accordingly. Market prices and figures are subject to revision. All investments in securities carry risk, including loss of principal. Readers must conduct their own due diligence and consult a SEBI-registered adviser and a qualified tax professional before acting. ShareBazaar Online accepts no liability for decisions taken on the basis of this content.